Poorvi Shah

ORCID: 0000-0002-2735-3944
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alcoholism and Thiamine Deficiency
  • Intensive Care Unit Cognitive Disorders
  • Anesthesia and Sedative Agents
  • Pharmaceutical Practices and Patient Outcomes
  • Diet and metabolism studies
  • Pelvic floor disorders treatments
  • Vitamin C and Antioxidants Research
  • Renal function and acid-base balance
  • Spinal Hematomas and Complications
  • Eicosanoids and Hypertension Pharmacology
  • Neurosurgical Procedures and Complications
  • Electroconvulsive Therapy Studies
  • Health and Wellbeing Research
  • Patient Safety and Medication Errors
  • Cardiac, Anesthesia and Surgical Outcomes

Advocate Christ Medical Center
2012-2022

Lilavati Hospital & Research Centre
2012

University College London
2006

Despite the established role of critical care pharmacist on ICU multiprofessional team, workloads are likely not optimized in ICU. Medication regimen complexity (as measured by Regimen Complexity-ICU [MRC-ICU] scoring tool) has been proposed as a potential metric to optimize workload but lacked robust external validation. The purpose this study was test hypothesis that MRC-ICU is related both patient outcomes and interventions diverse population.This multicenter, observational cohort...

10.1097/ccm.0000000000005585 article EN Critical Care Medicine 2022-06-09

Benzodiazepine (BZD)-resistant alcohol withdrawal remains a challenge for most institutions due to limited evidence with available agents. One published study currently exists utilizing the N-methyl-D-aspartate antagonist, ketamine, withdrawal.The purpose of our was evaluate effect adjunctive ketamine continuous infusion on symptom control and lorazepam requirements BZD-resistant patients in intensive care unit.A retrospective review conducted receiving adjunctively severe between August...

10.1007/s13181-018-0662-8 article EN cc-by Journal of Medical Toxicology 2018-05-10

Newsome, Andrea1; Rech, Megan2; Hammond, Drayton3; Liang, Edith4; Masic, Dalila5; Vilella, Antonia6; Smith, Melanie7; Plewa-Rusiecki, Angela8; Heavner, Mojdeh9; Dzierba, Amy10; Blackwell, Sarah11; Flannery, Alexander12; Shah, Poorvi13; Zachary14; Horng, Michelle15; Radosevich, John16; Hassig, Tanna17; Campbell, Joshua18; Montero, Jennifer19; PHARM-CRIT Study Investigators SCCM Author Information

10.1097/01.ccm.0000633196.63017.33 article EN Critical Care Medicine 2019-12-18

Introduction: Benzodiazepines (BZD) are initially used for treatment of alcohol withdrawal. Phenobarbital (PB) is a barbiturate agent that has also been in managing withdrawal symptoms, especially refractory to BZD. However, limited data available critically ill patients. The purpose our study describe institution’s experience with adjunctive PB use severe the intensive care unit (ICU). Hypothesis: can be safely adjunctively BZD symptoms ICU. Methods: A retrospective review was performed...

10.1097/01.ccm.0000425338.20578.d8 article EN Critical Care Medicine 2012-12-01

No AccessJournal of UrologyAdult urology1 Mar 2006Autonomic Dysreflexia: A Medical Emergency J. Bycroft, I.S. Shergill, E.A.L. Choong, N. Arya, and P.J.R. Shah BycroftJ. Bycroft More articles by this author , ShergillI.S. Shergill ChoongE.A.L. Choong AryaN. Arya ShahP.J.R. View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)00630-0AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Autonomic Emergency." The...

10.1016/s0022-5347(05)00630-0 article EN The Journal of Urology 2006-02-10
Coming Soon ...